asco 2018 - keynote 158 - keytruda in previously treated, now relapsing patients with sclc
Published 5 years ago • 552 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
11:15
asco 2018 - keynote 042 - keytruda as a single agent compared to doublet chemotherapy for nsclc
-
8:46
keytruda is now approved in combination with chemo for advanced non-squamous nsclc
-
7:54
keytruda combined with anti-vegf treatment:use in patients with advanced nsclc-asco lung review 2022
-
11:29
asco 2018 keynote189 - cisplatin or carboplatin with alimta & keytruda - practice changing approach?
-
4:26
asco 2018 - dream study - chemo with imfinzi (durvalumab) for mesothelioma
-
6:00
perioperative keytruda for early stage nsclc-leading developments & current questions in lung cancer
-
12:26
asco 2018 - potential showdown of two positive trials? keynote 407 and impower 131
-
6:32
asco 2019 lung cancer round table - new cancer research: long term outcomes of pembrolizumab
-
9:16
asco 2018 head and neck roundtable advances in immunotherapy in head and neck cancer
-
6:27
asco 2018 - tarceva combined with carboplatin & alimta - given upfront - affect pace of disease?
-
1:24
dr. strosberg discusses results for keynote-158
-
8:13
checkmate 816: combining chemo and opdivo - asco lung review 2022
-
11:42
asco lung cancer roundtable - nsclc trial updates: checkmate 227 opdivo yervoy combination today
-
10:44
what cancer patients should know: latest immunotherapy news from asco 2018
-
42:59
targeted therapies in lung cancer patient forum: love, sex and cancer